Coronavirus disease-2019 and its current scenario – A review

Showkat Ahmad Bhat, Gurjinder Singh, Waseem F. Bhat, Kumudini Borole, Ashraf Ali Khan
{"title":"Coronavirus disease-2019 and its current scenario – A review","authors":"Showkat Ahmad Bhat,&nbsp;Gurjinder Singh,&nbsp;Waseem F. Bhat,&nbsp;Kumudini Borole,&nbsp;Ashraf Ali Khan","doi":"10.1016/j.ceh.2021.09.002","DOIUrl":null,"url":null,"abstract":"<div><p>Coronaviruses are enveloped non-segmented positive-sense RNA viruses belonging to the family Coronaviridae. The human coronavirus infections are mild; the epidemics of the two β-coronaviruses, severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV) have caused more than ten thousand cumulative cases in the past twodecades. There is a new public health crisis threatening the world with the emergence and spread of 2019 novel coronavirus (2019-nCoV). The virus originated in bats and was transmitted to humans through yet unknown intermediary animals in Wuhan, Hubei province in China during the month of December 2019. Till date around 7,823,289 reported cases of coronavirus disease 2019 (COVID-2019) and 431,541 reported deaths till date. The disease is transmitted by inhalation or contact with infected droplets with incubation period of 2–14 days. The symptoms are usually fever, sore throat, dry cough, breathlessness, fatigue while many people are asymptomatic. Coronavirus (2019-nCoV) may progress to pneumonia, acute respiratory distress syndrome (ARDS) and can cause multi-organ dysfunction. Currently diagnosis is done by demonstration of the virus in respiratory secretions by special molecular tests like real-time reverse-transcription–polymerase-chain-reaction (RT-PCR), Radiological examinations (chest CT). Common laboratory tests like white cell counts and C-reactive protein (CRP) and measure symptoms can be used as preliminary screening at large scale after lock down the area or country. Treatment is essentially supportive; role of antiviral agents is yet to be established. It is paramount to implement infection control practices by infection source controlling, transmission route blocking, and susceptible population protection. Early preventive measures can be home isolation of suspected cases and those with mild illnesses and strict infection control measures at hospitals that include contact and droplet precautions. The worldwide impact of this Coronavirus new epidemic is yet uncertain.</p></div>","PeriodicalId":100268,"journal":{"name":"Clinical eHealth","volume":"4 ","pages":"Pages 67-73"},"PeriodicalIF":0.0000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2588914121000095/pdfft?md5=370d7bde0805693a86b891cacb3e40ad&pid=1-s2.0-S2588914121000095-main.pdf","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical eHealth","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2588914121000095","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

Abstract

Coronaviruses are enveloped non-segmented positive-sense RNA viruses belonging to the family Coronaviridae. The human coronavirus infections are mild; the epidemics of the two β-coronaviruses, severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV) have caused more than ten thousand cumulative cases in the past twodecades. There is a new public health crisis threatening the world with the emergence and spread of 2019 novel coronavirus (2019-nCoV). The virus originated in bats and was transmitted to humans through yet unknown intermediary animals in Wuhan, Hubei province in China during the month of December 2019. Till date around 7,823,289 reported cases of coronavirus disease 2019 (COVID-2019) and 431,541 reported deaths till date. The disease is transmitted by inhalation or contact with infected droplets with incubation period of 2–14 days. The symptoms are usually fever, sore throat, dry cough, breathlessness, fatigue while many people are asymptomatic. Coronavirus (2019-nCoV) may progress to pneumonia, acute respiratory distress syndrome (ARDS) and can cause multi-organ dysfunction. Currently diagnosis is done by demonstration of the virus in respiratory secretions by special molecular tests like real-time reverse-transcription–polymerase-chain-reaction (RT-PCR), Radiological examinations (chest CT). Common laboratory tests like white cell counts and C-reactive protein (CRP) and measure symptoms can be used as preliminary screening at large scale after lock down the area or country. Treatment is essentially supportive; role of antiviral agents is yet to be established. It is paramount to implement infection control practices by infection source controlling, transmission route blocking, and susceptible population protection. Early preventive measures can be home isolation of suspected cases and those with mild illnesses and strict infection control measures at hospitals that include contact and droplet precautions. The worldwide impact of this Coronavirus new epidemic is yet uncertain.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
2019冠状病毒病及其当前情况综述
冠状病毒是冠状病毒科的包膜非节段正义RNA病毒。人类冠状病毒感染是轻微的;严重急性呼吸综合征冠状病毒(SARS-CoV)和中东呼吸综合征冠状病毒(MERS-CoV)这两种β-冠状病毒的流行在过去二十年中累计造成了一万多例病例。随着2019年新型冠状病毒(2019- ncov)的出现和传播,一场新的公共卫生危机威胁着世界。该病毒起源于蝙蝠,并于2019年12月在中国湖北省武汉市通过尚不清楚的中间动物传播给人类。到目前为止,报告的2019年冠状病毒病(COVID-2019)病例约为7823289例,死亡病例约为431541例。该病通过吸入或接触受感染飞沫传播,潜伏期为2-14天。症状通常是发烧,喉咙痛,干咳,呼吸困难,疲劳,而许多人是无症状的。冠状病毒(2019-nCoV)可发展为肺炎、急性呼吸窘迫综合征(ARDS),并可导致多器官功能障碍。目前的诊断是通过实时逆转录聚合酶链反应(RT-PCR)、放射检查(胸部CT)等特殊分子检测在呼吸道分泌物中证实病毒。白细胞计数、c反应蛋白(CRP)等常规实验室检测和症状测量可作为封锁地区或国家后的大规模初步筛查。治疗基本上是支持性的;抗病毒药物的作用尚未确定。通过控制传染源、阻断传播途径和保护易感人群实施感染控制措施至关重要。早期预防措施可以是在家中隔离疑似病例和轻症患者,并在医院采取严格的感染控制措施,包括接触和飞沫预防措施。这种新型冠状病毒的全球影响尚不确定。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
8.10
自引率
0.00%
发文量
0
期刊最新文献
“AI et al.” The perils of overreliance on Artificial Intelligence by authors in scientific research A systematic review of eHealth and mHealth interventions for lymphedema patients Machine learning and transfer learning techniques for accurate brain tumor classification Internet of Things in healthcare: An adaptive ethical framework for IoT in digital health IoMT Tsukamoto Type-2 fuzzy expert system for tuberculosis and Alzheimer’s disease
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1